The targeting construct replaced exon 3 with one containing the mutation responsible for the amino acid substitution of leucine to alanine at position 43 (L43A). This mutation abolishes the function of the RAS-Binding domain. Flp-mediated recombination removed the FRT-flanked neomycin resistance cassette. (J:331473)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count